Schedule 13D ownership disclosure
CEREVEL THERAPEUTICS HLDNG I
Security class unavailable · CUSIP: 15678U128
Event date: 2024-08-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-24-000168
- Form type
- SC 13D
- Filer
- Cerevel Therapeutics Holdings, Inc.
- CIK
- CIK 1805387
- Filed
- Aug 05, 2024
- Reporting period
- Aug 01, 2024
- Description
- Schedule 13D beneficial ownership